Casey Ruess Email & Phone Number

Seattle, Washington, United States

Mainz, Rhineland-Palatinate, DE

Cambridge, Massachusetts, US

• Directed the Cell Management Operations program which included patient scheduling, apheresis collection shipping, drug product shipping, and courier management in support of clinical trial operations and drug product.
• Established the logistics and shipping systems strategy.
• Led the courier selection process.

Lawrence Township, NJ, US

• Led the Global Patient Scheduling and Cell Logistics teams that manage the geographically located command centers that coordinate and manage patient treatments with apheresis sites, treatment sites, logistics providers.
• Direct impact supporting early-stage clinical development to commercialization for BREYANZI® and ABECMA®.
• Organizational change management project in support of customer experience improvement project.

Seattle, WA, US

• JUNO THERAPEUTICS AQUIRED BY CELGENE, THEN BRISTOL MYERS SQUIBBLed the development and implementation of patient scheduling processes and infrastructure to support clinical and commercial patient scheduling. This.
• Expanded the organization from a one-person team in Seattle, supporting one clinical trial, to a global team of fifty-five employees across three regions, covering fifteen countries.
• Led the design, development, and implementation of the world class patient scheduling software.

Seattle, WA, US

Similar to the 'Associate Director, Global Patient Operations' role with less clinical assets and managing fewer team members.

Seal Beach, CA, US

• Managed the development and the day-to-day activities of the demand plan, capacity plan, and master treatment schedule across all locations and then collaborated with senior leadership in support of strategic.
• Direct impact supporting late-stage clinical development to commercialization for PROVENGE®.
• Led the Client Services Optimization Project by developing and implementing processes that aligned with department objectives.

Seal Beach, CA, US

• Responsible for scheduling and maintenance of activities related to patient needs, logistics, and manufacturing. This involved analyzing and planning in a highly capacity constrained, fast pace, and time sensitive.
• Developed the production planning strategy which maximizes the number of turns in the manufacturing sites.
• Participated in FDA capacity qualifications of the first three Dendreon manufacturing sites. Assisted in developing the timeline and process flow for the manufacturing site qualifications by leveraging knowledge of the.